| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 08/08/2001 | CN1069209C Medicine powdet for tuberculosis |
| 08/08/2001 | CN1069208C Juice for tonifying kidney and nourishing stomach |
| 08/08/2001 | CN1069207C Medicinal liquor for treating rheumatoid disease and preparation technology thereof |
| 08/08/2001 | CN1069205C Anticancer drug and its prep |
| 08/08/2001 | CN1069203C Drug for curing diabetes and its prep. |
| 08/08/2001 | CN1069202C Leigongma liquor and its prepn. method |
| 08/08/2001 | CN1069199C Placenta peptide oral liquid and its prodn. method |
| 08/08/2001 | CN1069198C Oral liquid for strengthening liver and preparating process thereof |
| 08/07/2001 | US6271368 Nucleotide sequences coding moduator of cellular activities; for the use in the prevention of plant consumption; viricides |
| 08/07/2001 | US6271204 Activation of pyruvate dehydrogenase phosphatase |
| 08/07/2001 | US6271028 Hematopoietic cell method for treatment of HIV infection |
| 08/07/2001 | US6270996 Enhancing conversion of single stranded adeno-associated virus to double stranded; infecting target cells with the recombinant virus and exposing the infected cells to an agent; gene therapy cancer and cystic fibrosis |
| 08/07/2001 | US6270989 A homologous recombinant dna construct comprising a targeting sequence, an exogenous regulatory sequence, an exon and an unpaired splice donor site at the 3'end; gene therapy for thrombopoietin, thrombocytopenia, multiple sclerosis |
| 08/07/2001 | US6270952 Methods for quenching pathogen inactivators in biological materials |
| 08/07/2001 | US6270811 Inactive culture of bacteria of the genus bifidobacterium compatible in cosmetics or pharmacy, in a mixture with an essential oil, and an organic acid. |
| 08/07/2001 | US6270808 Anti-viral isolates obtainable from leeches |
| 08/07/2001 | CA2222613C A device for delivering a preselected molecule into systemic circulation |
| 08/07/2001 | CA2051659C Platelet membrane microparticles |
| 08/07/2001 | CA1341281C Immunotherapy of tumor with monoclonal antibody against the 17-1a antigen |
| 08/02/2001 | WO2001055393A2 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1 |
| 08/02/2001 | WO2001055391A2 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| 08/02/2001 | WO2001055385A1 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and the metastases thereof |
| 08/02/2001 | WO2001055348A1 Improved inhibition of graft versus host disease |
| 08/02/2001 | WO2001055330A2 Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses |
| 08/02/2001 | WO2001055215A1 Therapeutic peptides |
| 08/02/2001 | WO2001055212A2 Delivery of therapeutic biological from implantable tissue matrices |
| 08/02/2001 | WO2001055182A1 PROTEINS COMPRISING CONSERVED REGIONS OF NEISSERIA MENINGITIDIS SURFACE ANTIGEN NhhA |
| 08/02/2001 | WO2001054727A1 Treatment of dermal tumors, warts, and viral infections using heat-killed p. acnes |
| 08/02/2001 | WO2001054722A1 Pre-transplant accommodated organs resistant to anti-donor immunity |
| 08/02/2001 | WO2001054717A1 Vaccine composition, process and methods |
| 08/02/2001 | WO2001054711A2 Use of neurotoxins for treating diabetes |
| 08/02/2001 | WO2001013932A3 Stimulation of sperm function |
| 08/02/2001 | WO2001007065A3 PRODUCTION OF rhPBGD AND NEW THERAPEUTIC METHODS FOR TREATING PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA (AIP) AND OTHER PORPHYRIC DISEASES |
| 08/02/2001 | WO2001005826A3 Chimeric polypeptides of serum albumin and uses related thereto |
| 08/02/2001 | WO2001004305A3 Human proteins involved in detoxification |
| 08/02/2001 | WO2001000828A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 08/02/2001 | WO2000047625A3 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith |
| 08/02/2001 | WO2000046391A9 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof |
| 08/02/2001 | US20010010933 Configuration; vectors; recombinants |
| 08/02/2001 | US20010010826 Contacting the site of wound with a matrix comprising gelatin and a nitric oxide scavanger to increase blood cirulation; nitric oxide scavanger are selected from L-arganine analog, dextran, heparin, cysteine and cystine |
| 08/02/2001 | US20010010821 For treatment of gastrointestinal disorders |
| 08/02/2001 | US20010010818 Methods and formulations for reducing circulating antibodies |
| 08/02/2001 | US20010010815 Adeno-associated vector compositions for expression of factor VIII |
| 08/02/2001 | DE10003801A1 Gentechnisch hergestellte insulin-sezernierende Surrogatzelle mit physiologischer Glucoseresponsivität Genetically engineered insulin-secreting cell surrogate with physiological Glucoseresponsivität |
| 08/02/2001 | DE10000443A1 Verfahren zur Herstellung eines kosmetisch verwendbaren Extraktes aus Meerschlick Process for the preparation of a cosmetically usable extract from sea mud |
| 08/02/2001 | CA2786722A1 Enhanced production of lipids containing polyenoic fatty acids by high density cultures of eukaryotic microbes in fermentors |
| 08/02/2001 | CA2398743A1 Novel mhc class ii restricted t cell epitopes from the cancer antigen, ny eso-1 |
| 08/02/2001 | CA2398401A1 Improved inhibition of graft versus host disease |
| 08/02/2001 | CA2398139A1 Proteins comprising conserved regions of neisseria meningitidis surface antigen nhha |
| 08/02/2001 | CA2397643A1 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and the metastases thereof |
| 08/02/2001 | CA2397267A1 Peptide fragments and uses thereof as type-1 interferon antagonist |
| 08/02/2001 | CA2396709A1 Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses |
| 08/02/2001 | CA2383626A1 Treatment of dermal tumors, warts, and viral infections using heat-killed p. acnes |
| 08/01/2001 | EP1120466A2 Use of negative regulation elements for nerve-specific expression of transgenes |
| 08/01/2001 | EP1119630A1 Nucleic acid constructs for genetic immunisation |
| 08/01/2001 | EP1119623A1 Mage-a3 peptides presented by hla class ii molecules |
| 08/01/2001 | EP1119615A1 PRODUCTION OF ssDNA IN VIVO |
| 08/01/2001 | EP1119584A1 Peptides related to an igf-ii-r epitope, polynucleotides encoding the peptides, and their use in immunomodulation |
| 08/01/2001 | EP1119581A1 METHODS OF INHIBITING SMOOTH MUSCLE CELL PROLIFERATION AND PREVENTING RESTENOSIS WITH A VECTOR EXPRESSING RB2/p130 |
| 08/01/2001 | EP1119565A1 Cytotoxic alkaloids (halitulin) |
| 08/01/2001 | EP1119376A2 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent |
| 08/01/2001 | EP1119252A2 Use of melanin for inhibition of angiogenesis and macular degeneration |
| 08/01/2001 | EP0885013B1 Use of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses for the preparation of medicaments |
| 08/01/2001 | EP0760675B1 Compositions comprising dna damaging agents and p53 |
| 08/01/2001 | EP0737074B1 Botulinum toxins for treating hyperhydrosis |
| 08/01/2001 | EP0633786B1 Method of inactivation of viral, parasitic and bacterial blood contaminants |
| 08/01/2001 | CN1306580A Mumbaistatin, process for its prodn. and its use as pharmaceutical |
| 08/01/2001 | CN1306576A G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 08/01/2001 | CN1306400A Drinks and foods capable of eliminating helicobacter pylori |
| 08/01/2001 | CN1306399A Additives for crustacean or fish feeds and feeds |
| 08/01/2001 | CN1306085A Application of substrate cell derived from fat tissue |
| 08/01/2001 | CN1305855A Physiotherapeutic card |
| 08/01/2001 | CN1305846A Diseases-resistant skin-protecting cream and its preparing process |
| 08/01/2001 | CN1305844A Medicine for treating congestive heart failure |
| 08/01/2001 | CN1305843A Exterior-applied Chinese-medicinal plaster for treating bone tuberculosis and its preparing process |
| 08/01/2001 | CN1305842A Chinese medicine for treating ovarian tumor |
| 08/01/2001 | CN1305840A Medicine for preventing and treating abortion |
| 08/01/2001 | CN1305837A Chinese medicine for treating male sexual disfunction |
| 08/01/2001 | CN1305835A Chinese medicine for treating angina pectonis |
| 08/01/2001 | CN1305833A Medicine for treating postoperative adhesion and its preparing process |
| 08/01/2001 | CN1305827A Chinese patent medicine for treating ulcer diseases |
| 08/01/2001 | CN1305824A Medicine for treating piles |
| 08/01/2001 | CN1305814A Medicine for treating oral ulcer |
| 08/01/2001 | CN1305813A Nail health disinfecting liquid |
| 08/01/2001 | CN1069062C Use of follicle-stimulating hormone |
| 08/01/2001 | CN1069059C Chinese patent medicine for treating epilepsy |
| 08/01/2001 | CN1069055C Pills for curing hyperosteogeny |
| 08/01/2001 | CN1069050C Compounded Chinese medicine for treating diabetes |
| 08/01/2001 | CN1069046C Liniment for treating bony spur |
| 08/01/2001 | CN1069043C Medicine for treating lithiasis |
| 08/01/2001 | CN1069037C Making method or oral capsule for curing difficult and complicated fracture |
| 08/01/2001 | CN1069035C Spirit for face nutrition |
| 08/01/2001 | CN1069034C Process and device for processing ants sectionally |
| 07/31/2001 | US6268483 Taking blood sample from patient, harvesting solution wich contains fibrin monomer, prothrombin, and factor xiii in certain concentrations, then forming fibrin polymer; for use in same patient |
| 07/31/2001 | US6268411 Use of multivalent chimeric peptide-loaded, MHC/ig molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses |
| 07/31/2001 | US6268215 Has nucleic acid encoding a human beta3 integrin subunit; enhances wound healing in graft procedures |
| 07/31/2001 | US6268180 A nucleic acid encoding a polypeptide; production of biologically active interleukin |
| 07/31/2001 | US6268172 A polynucleotide encoding a polypeptide for histidine kinase; screening and development of antibiotics for streptococcal diseases; otitis media, conjunctivitis, pneumonia, bacteremia pleural empyema, menegitis, sinusitis |
| 07/31/2001 | US6268120 Isoalloxazine derivatives to neutralize biological contaminants |
| 07/31/2001 | US6268119 Method for separating cells |